Plasmodium Immunotherapy for Advanced Ovarian Cancer
Clinical trial NCT05924776 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05924776
- Sponsor
- CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-20
- Primary completion
- 2026-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.